Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 54Thoracic 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Esophageal Neoplasms 6Liver Neoplasms 5Neoplasms 3Carcinoma, Hepatocellular 3Rectal Neoplasms 2Pancreatic Neoplasms 2Esophageal Squamous Cell Carcinoma 2Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Endometrial Neoplasms 1Deglutition Disorders 1Cholangiocarcinoma 1Biliary Tract Neoplasms 1Anal Canal Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 17Surveys and Questionnaires 12Specimen Handling 11Docetaxel 11Interviews as Topic 9Standard of Care 8Nivolumab 8Gemcitabine 8Early Intervention, Educational 8olaparib 7Magnetic Resonance Spectroscopy 7enzalutamide 6Psychiatric Rehabilitation 6Paclitaxel 6durvalumab 5Trastuzumab 5Radiotherapy 5Ipilimumab 5Carboplatin 5Bevacizumab 5pertuzumab 4palbociclib 4Therapeutics 4Taxes 4Oxaliplatin 4Methods 4Immunoglobulin G 4Fluorouracil 4Exercise 4Educational Status 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Brachytherapy × Gastrointestinal × Clear all
NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
43 enrolled 13 charts
GastrointestinalGenitourinaryGynecologic

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡